Company news

Median Technologies news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Median Technologies: H2 2025 Financial Communication Calendar

September 8, 2025

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025

September 4, 2025

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2025

August 7, 2025

Median Technologies Has Completed a Capital Increase of € 23.9 Million

August 1, 2025

CORRECTING and REPLACING: Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies launches an approximately €22 million capital increase to support commercialization of eyonis® LCS in the U.S....

July 23, 2025

Following the Signature of a Financial Agreement for up to €37.5 Million With the EIB, Median Technologies Launches an Approximately €22.0 Million Capital Increase to Support Commercialization of eyonis® LCS in the U.S. and to Finance Expansion...

July 21, 2025

Median Technologies Signs Financial Agreement for up to €37.5 Million New Financing Facility With the European Investment Bank (EIB)

July 11, 2025

Median Technologies: Half Year Liquidity Contract Statement

July 9, 2025

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2025

July 7, 2025

Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS

July 1, 2025

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2025

June 10, 2025

Median Technologies announces the availability of the preparatory documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 17, 2025

May 28, 2025

Median Technologies to Showcase iCRO’s Central and AI-Powered Imaging Services for Oncology Clinical Trials at ASCO 2025

May 27, 2025

Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2025

May 16, 2025

Median Technologies submits U.S. application for 510(k) clearance of eyonis® LCS

May 14, 2025

Median Technologies to Present Scientific Posters on eyonis® LCS in Two Major Health Conferences in North America in May 2025

May 12, 2025

Median Technologies to Participate in Several Investor Conferences in May and June 2025

May 6, 2025

Median Technologies Reports Full-year 2024 Financial Results

April 29, 2025

Median Technologies Reports 2025 Q1 Key Financial Indicators and Provides an Update on Q1 Key Operational Achievements

April 24, 2025

← Newer news releases

Decks

The 5 newest of 8 decks. Every deck is listed under its year.